FindTrial
Sign In

Evaluation of malaria relapse rate in Brazil

Evaluation of malaria relapse rate in Brazil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
REBEC
Registry ID
RBR-3n947j
Enrollment
Unknown
Registered
2016-10-31
Start date
2014-07-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malaria

Interventions

There is not a study intervention. This study will use secondary data from the epidemiological surveillance system (SIVEP Malária).This study does not require any clinical procedures, as it will use s
Other
L01.453.245.945.500

Sponsors

Fundação Oswaldo Cruz
Lead Sponsor
Fundação Oswaldo Cruz
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Positive diagnosis result (RDT, slide, PCR) and an evaluation of cure within 40/60 days in the selected areas.

Exclusion criteria

Exclusion criteria: Exclusion criteria of the patient data in the analysis: Absence of an evaluation of cure in the databank.

Design outcomes

Primary

MeasureTime frame
Proportion of patients with a second clinical malaria episode within 60 days after the treatment evaluate by thick blood smear.—

Secondary

MeasureTime frame
Time to relapse Falciparum / vivax recrudescence ratio Incidence in the population stratified by area and age range. Proportion of Early treatment failure Proportion of Late treatment failure—

Countries

Brazil

Contacts

Public ContactAndré Daher

Fundação Oswaldo Cruz

andredaher@gmail.com+552138829239

Outcome results

None listed

Source: REBEC (via WHO ICTRP)